Arcalis

Japanese Government Backs Arcalis with $115 Million Grants for mRNA Vaccine Production

Following Daiichi Sankyo’s recent accomplishment of securing Japan’s first mRNA vaccine approval, a potential competitor has emerged backed by significant ...